•
Sep 30, 2024

Oklo Q3 2024 Earnings Report

Oklo experienced customer pipeline growth and regulatory advancements.

Key Takeaways

Oklo made significant strides in Q3 2024, highlighted by an increase in the customer pipeline to 2,100 Megawatts, driven by new data center clients. The company also achieved key regulatory milestones, including DOE approval for the Fuel Fabrication Facility Design and secured an environmental compliance permit for the Idaho site. Additionally, Oklo began site preparation for its first powerhouse and signed a term sheet to acquire Atomic Alchemy, Inc.

Expanded customer pipeline to 2,100 MW with addition of two data center customers.

Received DOE approval for Fuel Fabrication Facility Design, a key step for using recovered nuclear material.

Secured environmental compliance permit for the Idaho site from the DOE, enabling site characterization.

Signed a term sheet to acquire Atomic Alchemy for radioisotope production, enhancing fuel recycling process.

Total Revenue
$0
EPS
-$0.08
Previous year: -$0.19
-57.9%
Gross Profit
-$68.7K
0
Cash and Equivalents
$91.8M
Previous year: $1.75M
+5147.4%
Free Cash Flow
-$7.99M
Previous year: -$3.46M
+131.2%
Total Assets
$294M
Previous year: $520M
-43.5%

Oklo

Oklo

Forward Guidance

Oklo anticipates continued progress in deploying their first commercial Aurora Powerhouse at Idaho National Laboratory (INL) in 2027.

Positive Outlook

  • Focus on building small-scale, modern fission powerhouses designed to be easily repeatable.
  • Selling power directly to customers, allowing for accelerated timelines and reduced complexity.
  • Aiming to lead in deploying advanced nuclear by late 2027 with a site permit and secured fuel.
  • Acquisition of Atomic Alchemy expected to enhance economics of nuclear fuel fabrication and recycling.
  • NRC proposed rule changes could expedite review process for new reactors.

Challenges Ahead

  • Risks related to the deployment of Oklo’s powerhouses.
  • The risk that Oklo is pursuing an emerging market, with no commercial project operating.
  • Regulatory uncertainties.
  • The potential need for financing to construct plants.
  • The risk that an agreement with Atomic Alchemy and the potential acquisition thereof do not materialize or fail to produce the expected benefits.